CA2929684C - Eye device - Google Patents
Eye device Download PDFInfo
- Publication number
- CA2929684C CA2929684C CA2929684A CA2929684A CA2929684C CA 2929684 C CA2929684 C CA 2929684C CA 2929684 A CA2929684 A CA 2929684A CA 2929684 A CA2929684 A CA 2929684A CA 2929684 C CA2929684 C CA 2929684C
- Authority
- CA
- Canada
- Prior art keywords
- agents
- drug delivery
- therapeutic agent
- sustained release
- delivery device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts or implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2240/00—Manufacturing or designing of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2240/001—Designing or manufacturing processes
- A61F2240/005—Templates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Nanotechnology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13192889.7 | 2013-11-14 | ||
| EP13192889 | 2013-11-14 | ||
| PCT/EP2014/074644 WO2015071427A1 (en) | 2013-11-14 | 2014-11-14 | Eye device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2929684A1 CA2929684A1 (en) | 2015-05-21 |
| CA2929684C true CA2929684C (en) | 2022-02-22 |
Family
ID=49584627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2929684A Active CA2929684C (en) | 2013-11-14 | 2014-11-14 | Eye device |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9999595B2 (https=) |
| EP (2) | EP3566693B1 (https=) |
| JP (1) | JP6602761B2 (https=) |
| KR (1) | KR20160085870A (https=) |
| CN (1) | CN105792812B (https=) |
| AU (1) | AU2014350095B9 (https=) |
| BR (1) | BR112016010638B1 (https=) |
| CA (1) | CA2929684C (https=) |
| CL (1) | CL2016001160A1 (https=) |
| EA (1) | EA032183B1 (https=) |
| ES (2) | ES2740352T3 (https=) |
| HK (1) | HK1223271A1 (https=) |
| IL (1) | IL245405A0 (https=) |
| MA (1) | MA39111A1 (https=) |
| MX (1) | MX2016006142A (https=) |
| TN (1) | TN2016000162A1 (https=) |
| WO (1) | WO2015071427A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10507101B2 (en) | 2014-10-13 | 2019-12-17 | W. L. Gore & Associates, Inc. | Valved conduit |
| US20160296532A1 (en) | 2015-04-13 | 2016-10-13 | Forsight Vision5, Inc. | Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent |
| US11523940B2 (en) | 2017-03-17 | 2022-12-13 | W. L. Gore & Associates, Inc. | Delivery aids for glaucoma shunts |
| US11690806B2 (en) | 2018-05-24 | 2023-07-04 | Celanese Eva Performance Polymers Llc | Implantable device for sustained release of a macromolecular drug compound |
| KR20260007295A (ko) | 2018-05-24 | 2026-01-13 | 셀라니즈 이브이에이 퍼포먼스 폴리머스 엘엘씨 | 거대 분자 약물 화합물의 지속적인 방출을 위한 이식가능 장치 |
| US11689849B2 (en) | 2018-05-24 | 2023-06-27 | Nureva, Inc. | Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones |
| JP2021532853A (ja) | 2018-07-23 | 2021-12-02 | ザ リージェンツ オブ ザ ユニヴァーシティ オブ コロラド，ア ボディ コーポレイト | 薬物送達のための眼科用装置 |
| AU2019333136B2 (en) | 2018-08-29 | 2022-11-17 | W. L. Gore & Associates, Inc. | Drug therapy delivery systems and methods |
| US11678983B2 (en) | 2018-12-12 | 2023-06-20 | W. L. Gore & Associates, Inc. | Implantable component with socket |
| CN118718181A (zh) | 2019-06-05 | 2024-10-01 | 里珍纳龙药品有限公司 | 用于精确剂量递送的装置及方法 |
| GB2601922B (en) | 2019-06-27 | 2024-04-24 | Layerbio Inc | Ocular device drub delivery systems |
| US11399977B2 (en) | 2020-06-04 | 2022-08-02 | SpyGlass Pharma, Inc. | Ophthalmic implant system for drug delivery |
| BR112023022439A2 (pt) | 2021-04-26 | 2023-12-26 | Celanese Eva Performance Polymers Llc | Dispositivo implantável para liberação sustentada de um composto de fármaco macromolecular |
| US12527691B2 (en) | 2021-11-05 | 2026-01-20 | W. L. Gore & Associates, Inc. | Fluid drainage devices, systems, and methods |
| US20230149298A1 (en) * | 2021-11-17 | 2023-05-18 | Celanese Eva Performance Polymers Llc | Implantable Device for Treating an Inflammatory Eye Condition |
| CN114224822B (zh) * | 2022-01-28 | 2023-07-14 | 复旦大学附属眼耳鼻喉科医院 | 一种眼部缓释给药植入物及其制造方法 |
| EP4233836B1 (en) * | 2022-02-24 | 2024-11-06 | Eyed Pharma | Intraocular drug delivery device comprising an eyelet |
| WO2024020505A2 (en) * | 2022-07-22 | 2024-01-25 | SpyGlass Pharma, Inc. | Intraocular drug delivery systems and methods of use |
| US12193972B2 (en) | 2022-07-22 | 2025-01-14 | SpyGlass Pharma, Inc. | Intraocular drug delivery systems and methods of use |
| USD1120314S1 (en) | 2022-11-30 | 2026-03-24 | Regeneron Pharmaceuticals, Inc. | Dose delivery device |
| WO2025005478A1 (ko) * | 2023-06-27 | 2025-01-02 | 주식회사 뷰아이비전 | 안구용 임플란트 |
| KR102783540B1 (ko) * | 2023-12-22 | 2025-03-17 | 조선대학교산학협력단 | 인공수정체 및 이의 제조방법 |
| WO2026022371A1 (en) | 2024-07-26 | 2026-01-29 | Eyed Pharma Sa | Retainer for intraocular drug delivery device |
| WO2026022370A1 (en) | 2024-07-26 | 2026-01-29 | Eyed Pharma Sa | Injector for intraocular drug delivery device |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3416530A (en) | 1966-03-02 | 1968-12-17 | Richard A. Ness | Eyeball medication dispensing tablet |
| US3618604A (en) | 1969-06-09 | 1971-11-09 | Alza Corp | Ocular insert |
| US3710795A (en) | 1970-09-29 | 1973-01-16 | Alza Corp | Drug-delivery device with stretched, rate-controlling membrane |
| US4069307A (en) | 1970-10-01 | 1978-01-17 | Alza Corporation | Drug-delivery device comprising certain polymeric materials for controlled release of drug |
| US4014335A (en) | 1975-04-21 | 1977-03-29 | Alza Corporation | Ocular drug delivery device |
| US4144317A (en) | 1975-05-30 | 1979-03-13 | Alza Corporation | Device consisting of copolymer having acetoxy groups for delivering drugs |
| US4668506A (en) | 1985-08-16 | 1987-05-26 | Bausch & Lomb Incorporated | Sustained-release formulation containing and amino acid polymer |
| US4959217A (en) * | 1986-05-22 | 1990-09-25 | Syntex (U.S.A.) Inc. | Delayed/sustained release of macromolecules |
| US4718905A (en) * | 1986-08-13 | 1988-01-12 | Freeman Jerre M | Haptic element using ion beam implantation for an intraocular lens |
| US4997652A (en) | 1987-12-22 | 1991-03-05 | Visionex | Biodegradable ocular implants |
| US5164188A (en) | 1989-11-22 | 1992-11-17 | Visionex, Inc. | Biodegradable ocular implants |
| US5178635A (en) | 1992-05-04 | 1993-01-12 | Allergan, Inc. | Method for determining amount of medication in an implantable device |
| US5443505A (en) | 1993-11-15 | 1995-08-22 | Oculex Pharmaceuticals, Inc. | Biocompatible ocular implants |
| US5773019A (en) * | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| US5928282A (en) * | 1997-06-13 | 1999-07-27 | Bausch & Lomb Surgical, Inc. | Intraocular lens |
| US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
| FR2787991B1 (fr) * | 1998-12-31 | 2001-05-25 | Medicale De Prec S M P Sa Soc | Dispositif pour traiter la presbytie ou autre affection oculaire |
| US7090888B2 (en) * | 2002-01-18 | 2006-08-15 | Snyder Michael E | Sustained release ophthalmological device and method of making and using the same |
| FR2844703B1 (fr) * | 2002-09-25 | 2005-07-08 | Alain Nicolas Gilg | Dispositif intraoculaire pour restaurer l'accommodation de l'oeil atteint de presbytie |
| US20090018650A1 (en) * | 2003-06-19 | 2009-01-15 | Boxer Wachler Brian S | Ophthalmological zonular stretch segment for treating presbyopia |
| US8003124B2 (en) * | 2005-04-08 | 2011-08-23 | Surmodics, Inc. | Sustained release implants and methods for subretinal delivery of bioactive agents to treat or prevent retinal disease |
| JP5591226B2 (ja) * | 2008-05-12 | 2014-09-17 | ユニバーシティ・オブ・ユタ・リサーチ・ファウンデイション | 眼内薬物送達装置および関連する方法 |
| JP6002385B2 (ja) * | 2008-09-12 | 2016-10-05 | クリティカル ファーマシューティカルズ リミテッドＣｒｉｔｉｃａｌ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｉｍｉｔｅｄ | 医薬組成物、医薬組成物における吸収促進剤の使用方法、及び医薬組成物の製造方法 |
| US20100226962A1 (en) | 2009-03-03 | 2010-09-09 | Rodstrom Theron R | Peri-corneal drug delivery device |
| EP2555749B1 (en) * | 2010-04-06 | 2016-10-26 | Allergan, Inc. | Sustained-release reservoir implants for intracameral drug delivery |
-
2014
- 2014-11-14 CA CA2929684A patent/CA2929684C/en active Active
- 2014-11-14 AU AU2014350095A patent/AU2014350095B9/en active Active
- 2014-11-14 CN CN201480062417.9A patent/CN105792812B/zh active Active
- 2014-11-14 ES ES14809301T patent/ES2740352T3/es active Active
- 2014-11-14 MA MA39111A patent/MA39111A1/fr unknown
- 2014-11-14 BR BR112016010638-5A patent/BR112016010638B1/pt active IP Right Grant
- 2014-11-14 US US15/034,869 patent/US9999595B2/en active Active
- 2014-11-14 HK HK16111409.4A patent/HK1223271A1/zh unknown
- 2014-11-14 EP EP19165620.6A patent/EP3566693B1/en active Active
- 2014-11-14 EP EP14809301.6A patent/EP3068372B1/en active Active
- 2014-11-14 KR KR1020167015621A patent/KR20160085870A/ko not_active Withdrawn
- 2014-11-14 TN TN2016000162A patent/TN2016000162A1/en unknown
- 2014-11-14 WO PCT/EP2014/074644 patent/WO2015071427A1/en not_active Ceased
- 2014-11-14 EA EA201690967A patent/EA032183B1/ru not_active IP Right Cessation
- 2014-11-14 ES ES19165620T patent/ES2864274T3/es active Active
- 2014-11-14 MX MX2016006142A patent/MX2016006142A/es unknown
- 2014-11-14 JP JP2016531690A patent/JP6602761B2/ja active Active
-
2016
- 2016-05-02 IL IL245405A patent/IL245405A0/en unknown
- 2016-05-13 CL CL2016001160A patent/CL2016001160A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3068372A1 (en) | 2016-09-21 |
| TN2016000162A1 (en) | 2017-10-06 |
| IL245405A0 (en) | 2016-06-30 |
| JP6602761B2 (ja) | 2019-11-06 |
| ES2740352T3 (es) | 2020-02-05 |
| KR20160085870A (ko) | 2016-07-18 |
| EP3068372B1 (en) | 2019-05-08 |
| US9999595B2 (en) | 2018-06-19 |
| EA201690967A1 (ru) | 2016-10-31 |
| WO2015071427A1 (en) | 2015-05-21 |
| BR112016010638A2 (https=) | 2017-08-08 |
| EP3566693B1 (en) | 2021-02-17 |
| AU2014350095A1 (en) | 2016-06-09 |
| EA032183B1 (ru) | 2019-04-30 |
| MA39111A1 (fr) | 2017-04-28 |
| US20160287513A1 (en) | 2016-10-06 |
| CL2016001160A1 (es) | 2017-03-17 |
| CA2929684A1 (en) | 2015-05-21 |
| AU2014350095B9 (en) | 2019-09-12 |
| ES2864274T3 (es) | 2021-10-13 |
| CN105792812B (zh) | 2020-10-23 |
| CN105792812A (zh) | 2016-07-20 |
| JP2016537370A (ja) | 2016-12-01 |
| BR112016010638B1 (pt) | 2023-01-31 |
| HK1223271A1 (zh) | 2017-07-28 |
| AU2014350095B2 (en) | 2019-08-29 |
| MX2016006142A (es) | 2016-12-09 |
| EP3566693A1 (en) | 2019-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2929684C (en) | Eye device | |
| AU2020204427B2 (en) | Drug eluting ocular implant | |
| US10881609B2 (en) | Methods for treating eye disorders using ocular implants | |
| JP5009786B2 (ja) | ２ヶ月を超える期間の長期持続放出を与えるステロイド眼内インプラント | |
| AU2014241163B2 (en) | Ophthalmic implant for delivering therapeutic substances | |
| JP7519413B2 (ja) | 眼科用薬剤組成物、眼科用キット、及びその医学的応用 | |
| JP2014236980A (ja) | 治療薬剤の持続放出のための薬物コア | |
| WO2016064959A1 (en) | Two-layer ocular implant comprising a tyrosine kinase inhibitor | |
| Gote et al. | Ocular implants in the clinic and under clinical investigation for ocular disorders | |
| HK1155104B (en) | Drug cores for sustained release of therapeutic agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 10TH ANNIV.) - STANDARD Year of fee payment: 10 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241105 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20241105 Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20241105 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD Year of fee payment: 11 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251104 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251104 |